Tag: molnupiravir
Merck: WHO recommends molnupiravir for people at high risk
By Jean-Baptiste Andre Published on 03/03/2022 at 2:21 p.m. Photo credit © Reuters …
Merck sees sales for 2022 increase by almost 20%, mainly thanks to molnupiravir.
The drugmaker said sales of the COVID-19 drug rose to $952 million in the fourth quarter, and it expects additional sales of $5-6 billion for the drug in 2022. Merck…
Merck and co inc: Molnupiravir supply agreement with UNICEF
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Merck and co inc: molnupiravir approved for emergency in Japan
Receive free each morning the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and,…
Merck: molnupiravir approved for emergency in Japan
(CercleFinance.com) – Merck and Ridgeback announce that the Japanese Ministry of Health has granted special emergency approval in Japan for molnupiravir, their experimental oral antiviral drug for infectious diseases caused…